Literature DB >> 1849367

Effects of purine derivatives on calcitriol metabolism in rats.

C H Hsu1, S R Patel, E W Young, R Vanholder.   

Abstract

The effects of theophylline and sodium urate on metabolic production (PR) and clearance rate (MCR) of calcitriol were determined by the constant isotope infusion method in normal rats. Calcitriol PR was significantly reduced after infusion for 20 h of either theophylline (1 mg/h, PR = 22.3 +/- 1.6 ng.kg-1.day-1, P less than 0.001, n = 5) or sodium urate (0.5 mg/h, PR = 18.6 +/- 1.2 ng.kg-1.day-1, P less than 0.001, n = 5) compared with control rats infused with saline (PR = 32.0 +/- 1.5 ng.kg-1.day-1, n = 5). Renal 1 alpha-hydroxylase activity of kidney homogenate was significantly inhibited in rats infused with theophylline or urate. Suppression of 1 alpha-hydroxylase activity was also observed when the kidney homogenate was preincubated for 3 h with various concentrations of xanthine (0.11-3.0 mg/dl). In addition, the MCR of calcitriol was decreased in rats infused with either theophylline (MCR = 21.0 +/- 0.88 microliter.min-1.100 g-1, P less than 0.005) or urate (MCR = 22.9 +/- 0.91 microliter.min-1.100 g-1, P less than 0.05) compared with saline-infused control rats (MCR = 25.2 +/- 0.41 microliter.min-1.100 g-1). Because calcitriol degradation is a receptor-mediated process that requires binding of the receptor-hormone complex to chromatin, we studied the binding affinity of labeled calcitriol receptor for DNA-cellulose in the presence of theophylline or urate. Both theophylline and urate inhibited receptor binding affinity for DNA-cellulose. We conclude that these purine derivatives suppress calcitriol synthesis and inhibit receptor binding affinity for DNA. The altered receptor binding affinity could explain the decreased MCR of calcitriol.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849367     DOI: 10.1152/ajprenal.1991.260.4.F596

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

1.  Demographic, dietary, and serum factors and parathyroid hormone in the National Health and Nutrition Examination Survey.

Authors:  J M Paik; W R Farwell; E N Taylor
Journal:  Osteoporos Int       Date:  2011-09-20       Impact factor: 4.507

Review 2.  The role of uric acid in mineral bone disorders in chronic kidney disease.

Authors:  Baris Afsar; Alan A Sag; Cinar Oztosun; Masanari Kuwabara; Mario Cozzolino; Adrian Covic; Mehmet Kanbay
Journal:  J Nephrol       Date:  2019-04-27       Impact factor: 3.902

Review 3.  Factors influencing drug protein binding in patients with end stage renal failure.

Authors:  R Vanholder; R De Smet; S Ringoir
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 4.  Uric acid, hypertension, and cardiovascular and renal complications.

Authors:  Carmine Zoccali; Francesca Mallamaci
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

5.  Association between serum uric acid and bone health in adolescents.

Authors:  F Karimi; M H Dabbaghmanesh; G R Omrani
Journal:  Osteoporos Int       Date:  2019-07-04       Impact factor: 4.507

Review 6.  Allopurinol, uric acid, and oxidative stress in cardiorenal disease.

Authors:  Markus Riegersperger; Adrian Covic; David Goldsmith
Journal:  Int Urol Nephrol       Date:  2011-03-10       Impact factor: 2.370

7.  Calcitriol Treatment Attenuates Uric Acid-Induced Kidney Injury via Super Oxide Dismutase-1 (SOD-1) Upregulation and Fibrosis Reduction

Authors:  Muhammad Mansyur Romi; Nur Arefian; Wiwit Ananda Wahyu Setyaningsih; Rachma Greta Perdana Putri; Mohammad Juffrie; Dwi Cahyani Ratna Sari
Journal:  Iran Biomed J       Date:  2021-11-01

8.  Uric acid suppresses 1 alpha hydroxylase in vitro and in vivo.

Authors:  Wei Chen; Carlos Roncal-Jimenez; Miguel Lanaspa; Smits Gerard; Michel Chonchol; Richard J Johnson; Diana Jalal
Journal:  Metabolism       Date:  2013-10-23       Impact factor: 8.694

Review 9.  Impaired vitamin D metabolism in CKD.

Authors:  Cortney Bosworth; Ian H de Boer
Journal:  Semin Nephrol       Date:  2013-03       Impact factor: 5.299

Review 10.  Recommendations on the measurement and the clinical use of vitamin D metabolites and vitamin D binding protein - A position paper from the IFCC Committee on bone metabolism.

Authors:  Konstantinos Makris; Harjit P Bhattoa; Etienne Cavalier; Karen Phinney; Christopher T Sempos; Candice Z Ulmer; Samuel D Vasikaran; Hubert Vesper; Annemieke C Heijboer
Journal:  Clin Chim Acta       Date:  2021-03-10       Impact factor: 6.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.